FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033916096> ?p ?o ?g. }

• W3033916096 abstract "Abstract Background and Aims ADPKD is the most common inherited kidney disease in man, a major cause of end-stage renal disease and is a significant medical and economic burden across Europe. However the impact of this major disease on the quality of life of patients with preserved kidney function has not been systematically explored. Method The CYSTic 1 study was an academic prospective study designed to study the natural history of ADPKD, the impact of the disease on individual patients and the health economic costs on care systems across Europe in adult patients with preserved kidney function (eGFR ≥30 mls/min). Around 400 patients were recruited from 6 expert centres across Europe (Belgium, France, Italy, Netherlands, Spain, UK) with baseline clinical data recorded including HR-QOL (Health-Related Quality of Life) incorporating a Kidney Disease QOL short form (KDQOL-SF v1.3 questionnaire), renal MRI for TKV (Total Kidney Volume) and DNA for genotyping. Here we report initial results based on baseline HR-QOL data in the UK patients. Results Detailed analysis was conducted on 76 patients recruited from a single centre (UK) whose mean age was 43 years, 53.9% were female with a mean eGFR-EPI of 69ml/min/1.73m2 and mean height-adjusted TKV (Ht-TKV) of 664ml/m. The cohort was subdivided by groups based on eGFR stage (I, II, III), Ht-TKV (&lt;&gt;750ml/m) and genotype (PKD1 v PKD2/NMD) and correlated with HR-QOL scores. As expected, age, hypertension and Ht-TKV were significantly associated with eGFR stage. Of interest, flank pain was more frequently reported in patients with smaller kidneys (Ht-TKV&lt;750) and patients with PKD1 more likely to be hypertensive. All QOL scores (SF36) were significantly lower in patients with progressively lower eGFR except for emotional well-being whereas Symptom/problem (p=0.043) and Sleep (p=0.021) (KDQOL-SF1.3) were significantly worse in patients with lower kidney function. SF36 scores for Physical functioning (p=0.001), General health (p=0.026) and physical component summary (PCS) (P=0.019) decreased in patients with more advanced disease defined by larger kidneys (ht-TKV&gt;750). Conclusion In ADPKD patients with stage 1-3 chronic kidney disease (CKD), stepwise lower QOL scores were consistently found and significantly associated with decreasing eGFR. A notable reported item was disturbed sleep. Unexpectedly, patients with smaller kidneys reported significantly more flank pain. PKD1 patients and those with large kidneys were more likely to be hypertensive. Our results suggest that the impact of ADPKD on patients with stage 1-3 CKD is underestimated. Future work will investigate possible national differences and the relationship of HR-QOL with markers of disease within the entire cohort." @default.
• W3033916096 created "2020-06-12" @default.
• W3033916096 creator A5015914541 @default.
• W3033916096 creator A5017385241 @default.
• W3033916096 creator A5080552892 @default.
• W3033916096 date "2020-06-01" @default.
• W3033916096 modified "2023-10-16" @default.
• W3033916096 title "SO092REDUCED QUALITY OF LIFE IN ADPKD PATIENTS WITH CKD STAGE 1-3: THE CYSTIC I QUALITY OF LIFE STUDY" @default.
• W3033916096 doi "https://doi.org/10.1093/ndt/gfaa139.so092" @default.
• W3033916096 hasPublicationYear "2020" @default.
• W3033916096 type Work @default.
• W3033916096 sameAs 3033916096 @default.
• W3033916096 citedByCount "0" @default.
• W3033916096 crossrefType "journal-article" @default.
• W3033916096 hasAuthorship W3033916096A5015914541 @default.
• W3033916096 hasAuthorship W3033916096A5017385241 @default.
• W3033916096 hasAuthorship W3033916096A5080552892 @default.
• W3033916096 hasConcept C126322002 @default.
• W3033916096 hasConcept C146357865 @default.
• W3033916096 hasConcept C151730666 @default.
• W3033916096 hasConcept C159110408 @default.
• W3033916096 hasConcept C159641895 @default.
• W3033916096 hasConcept C2776266639 @default.
• W3033916096 hasConcept C2778653478 @default.
• W3033916096 hasConcept C2779134260 @default.
• W3033916096 hasConcept C2779951463 @default.
• W3033916096 hasConcept C71924100 @default.
• W3033916096 hasConcept C72563966 @default.
• W3033916096 hasConcept C86803240 @default.
• W3033916096 hasConceptScore W3033916096C126322002 @default.
• W3033916096 hasConceptScore W3033916096C146357865 @default.
• W3033916096 hasConceptScore W3033916096C151730666 @default.
• W3033916096 hasConceptScore W3033916096C159110408 @default.
• W3033916096 hasConceptScore W3033916096C159641895 @default.
• W3033916096 hasConceptScore W3033916096C2776266639 @default.
• W3033916096 hasConceptScore W3033916096C2778653478 @default.
• W3033916096 hasConceptScore W3033916096C2779134260 @default.
• W3033916096 hasConceptScore W3033916096C2779951463 @default.
• W3033916096 hasConceptScore W3033916096C71924100 @default.
• W3033916096 hasConceptScore W3033916096C72563966 @default.
• W3033916096 hasConceptScore W3033916096C86803240 @default.
• W3033916096 hasLocation W30339160961 @default.
• W3033916096 hasOpenAccess W3033916096 @default.
• W3033916096 hasPrimaryLocation W30339160961 @default.
• W3033916096 hasRelatedWork W11483127 @default.
• W3033916096 hasRelatedWork W1381810 @default.
• W3033916096 hasRelatedWork W1930163 @default.
• W3033916096 hasRelatedWork W2453854 @default.
• W3033916096 hasRelatedWork W4106645 @default.
• W3033916096 hasRelatedWork W4374720 @default.
• W3033916096 hasRelatedWork W6994576 @default.
• W3033916096 hasRelatedWork W8128396 @default.
• W3033916096 hasRelatedWork W9887750 @default.
• W3033916096 hasRelatedWork W4359684 @default.
• W3033916096 isParatext "false" @default.
• W3033916096 isRetracted "false" @default.
• W3033916096 magId "3033916096" @default.
• W3033916096 workType "article" @default.